DJIA 17,813.39 1.20 0.01%
NASDAQ 5,116.14 0.00 0.00%
S&P 500 2,088.87 0.00 0.00%
market minute promo

Synageva BioPharma (NASDAQ: GEVA)

0.00 0.00 (0.00%)

Quote as of

company name or ticker

Recent Quotes

GEVA $0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $0.00 - $0.00
Market Cap $0.00
P/E Ratio 0.00
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS -$7.23




Drug Makers

Synageva BioPharma (GEVA) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of a new class of antiviral drug treatments called fusion inhibitors. Website:

News & Commentary Rss Feed

This Drugmaker's Incredible Run Looks Far From Done

Alexion Pharmaceuticals has been a biotech investor's dream stock for years and has created a fortune for patient investors. But with a strong product lineup and healthy pipeline, the future looks great, too.

Columbia Wanger Sells 22 Stakes in Second Quarter

Bluebird, Pacira Pharmaceuticals Excite Life Science Investors

Ultragenyx Downgraded At Morgan Stanley, Valuation 'Stretched' And Pipeline Faces Execution Risk

JMP Starts Ultragenyx At Outperform, Pipeline Maturity Expected To Continue

Is it Time for this Biotech to Change Management?

With Aegerion Pharmaceuticals down 500% from its all-time high, the current CEO's tenure is trying investors' patience.

Bernstein: Alexion Pharma An Outperform, Worth $267/Share

New Lifetime High Today: Synageva BioPharma (GEVA)

5 Healthy Stocks in the Top Biotech ETF - ETF News And Commentary

13.8% Annual Return With Synageva BioPharma

See More GEVA News...

GEVA's Top Competitors

GEVA $0.00 (0.00%)
Current stock: GEVA
AMGN $163.95 (0.00%)
Current stock: AMGN
GILD $107.78 (0.00%)
Current stock: GILD
BIIB $292.30 (0.00%)
Current stock: BIIB